Evidence map›Paper›PMID 27336706›Full record

ArticleNature protocols2016

Chemoenzymatic synthesis of the bacterial polysaccharide repeating unit undecaprenyl pyrophosphate and its analogs.

Lei Li, Robert L Woodward, Weiqing Han, Jingyao Qu, Jing Song, Cheng Ma, Peng G Wang

Abstract read
In one paragraph

Article in Nature protocols, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Targeting the Sugary Armor ofFrontiers in cellular and infection microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lei LiDepartment of Chemistry and Center for Diagnostics &Therapeutics, Georgia State University, Atlanta, Georgia, USA.
Robert L WoodwardDepartment of Chemistry and Biochemistry, University of Mount Union, Alliance, Ohio, USA.
Weiqing HanDepartment of Chemistry and Center for Diagnostics &Therapeutics, Georgia State University, Atlanta, Georgia, USA.
Jingyao QuDepartment of Chemistry and Center for Diagnostics &Therapeutics, Georgia State University, Atlanta, Georgia, USA.
Jing SongDepartment of Chemistry and Center for Diagnostics &Therapeutics, Georgia State University, Atlanta, Georgia, USA.
Cheng MaDepartment of Chemistry and Center for Diagnostics &Therapeutics, Georgia State University, Atlanta, Georgia, USA.
Peng G WangDepartment of Chemistry and Center for Diagnostics &Therapeutics, Georgia State University, Atlanta, Georgia, USA.
Georgia State University · USUniversity of Mount Union · US

Funding

Research and Development of a Novel System to Produce Polysaccharide Conjugate VaR01AI083754 · NIAID · OHIO STATE UNIVERSITY · PI WANG, PENG GEORGE · 2009 to 2016
$2.7M
Biosynthesis of PolysaccharidesR01GM085267 · NIGMS · OHIO STATE UNIVERSITY · PI WANG, PENG GEORGE · 2009 to 2017
$2.4M
Facile Synthesis of O-Glycans and O-GlycopeptidesU01GM116263 · NIGMS · GEORGIA STATE UNIVERSITY · PI LI, LEI · 2015 to 2018
$2.2M
NIAID NIH HHS R01 AI083754NIGMS NIH HHS R01 GM085267NIGMS NIH HHS U01 GM116263
6 · The paper itself

Abstract

Polysaccharides are essential and immunologically relevant components of bacterial cell walls. These biomolecules can be found covalently attached to lipids (e.g., O-polysaccharide (PS) contains undecaprenyl and lipopolysaccharide (LPS) contains lipid A) or noncovalently associated with cell wells (e.g., capsular PS (CPS)). Although extensive genetic studies have indicated that the Wzy-dependent biosynthetic pathway is primarily responsible for producing such polysaccharides, in vitro biochemical studies are needed to determine, for example, which gene product is responsible for catalyzing each step in the pathway, and to reveal molecular details about the Wzx translocase, Wzy polymerase and O-PS chain-length determinant. Many of these biochemical studies require access to a structurally well-defined PS repeating unit undecaprenyl pyrophosphate (RU-PP-Und), the key building block in this pathway. We describe herein the chemoenzymatic synthesis of Escherichia coli (serotype O157) RU-PP-Und. This involves (i) chemical synthesis of precursor N-acetyl-D-galactosamine (GalNAc)-PP-Und (2 weeks) and (ii) enzymatic extension of the precursor to produce RU-PP-Und (2 weeks). Undecaprenyl phosphate and peracetylated GalNAc-1-phosphate are prepared from commercially available undecaprenol and peracetylated GalNAc. The chemical coupling of these two products, followed by structural confirmation (mass spectrometry and NMR) and deprotection, generates GalNAc-PP-Und. This compound is then sequentially modified by enzymes in the E. coli serotype O157 (E. coli O157) O-PS biosynthetic pathway. Three glycosyltransferases (GTs) are involved (WbdN, WbdO and WbdP) and they transfer glucose (Glc), L-fucose (L-Fuc) and N-acetylperosamine (PerNAc) onto GalNAc-PP-Und to form the intact RU-PP-Und in a stepwise manner. Final compounds and intermediates are confirmed by mass spectrometry. The procedure can be adapted to the synthesis of analogs with different PS or lipid moieties.

Indexed as

Biosynthetic PathwaysAcetylgalactosamineBacterial ProteinsEscherichia coliEscherichia coli ProteinsGlycosyltransferasesMultigene FamilyPolyisoprenyl PhosphatesPolysaccharides, BacterialAcetylgalactosamineBacterial ProteinsEscherichia coli ProteinsGlycosyltransferasesPolyisoprenyl PhosphatesPolysaccharides, Bacterialrfb protein, Bacteriaundecaprenyl pyrophosphate

Identifiers

PMID27336706
PMCPMC5953200
OpenAlexW2466894347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.